Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 2 Multicenter, Double-blind, Randomized, Parallel-Group, Vehicle-Controlled Study to Evaluate the Efficacy, Safety, and Local Tolerability of G001 in Patients With Osteoarthritis (OA) of the Knee

NCT05007808 is registered in ClinicalTrials.gov with BUZZZ Pharmaceuticals Limited as lead sponsor.

NCT NCT05007808
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05007808 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 2 Multicenter, Double-blind, Randomized, Parallel-Group, Vehicle-Controlled Study to Evaluate the Efficacy, Safety, and Local Tolerability of G001 in Patients With Osteoarthritis (OA) of the Knee
Lead sponsor
BUZZZ Pharmaceuticals Limited
Phase
Phase 2
Overall status
Completed
Start date
January 6, 2021
Completion date
January 10, 2023
Enrollment
210 (actual)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

osteoarthritis, knee